Skip to main content
Livermore
Livermore
ZHEN

Wealthcare Advisory Partners LLC

SEC CIK
0001683059
Latest filing
Jul 9, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Wealthcare Advisory Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
4,627
Value
$2.30M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Wealthcare Advisory Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,627$2.30M<0.1%−215−4.4%ReducedHolders
Q1 20264,842$2.16M<0.1%−417−7.9%ReducedHolders
Q4 20255,259$2.38M<0.1%+130+2.5%AddedHolders
Q3 20255,129$2.01M<0.1%+1,967+62.2%AddedHolders
Q2 20253,162$1.41M<0.1%−29−0.9%ReducedHolders
Q1 20253,191$1.55M<0.1%−70−2.1%ReducedHolders
Q4 20243,261$1.31M<0.1%+172+5.6%AddedHolders
Q3 20243,089$1.44M<0.1%−239−7.2%ReducedHolders
Q2 20243,328$1.56M<0.1%+110+3.4%AddedHolders
Q1 20243,218$1.35M<0.1%+141+4.6%AddedHolders
Q4 20233,077$1.25M<0.1%−41−1.3%ReducedHolders
Q3 20233,118$1.08M<0.1%−33−1.0%ReducedHolders
Q2 20233,151$1.11M<0.1%−208−6.2%ReducedHolders
Q1 20233,359$1.06M<0.1%−91−2.6%ReducedHolders
Q4 20223,450$996.3K<0.1%+91+2.7%AddedHolders
Q3 20223,359$973.0K0.1%+156+4.9%AddedHolders
Q2 20223,203$903.0K0.1%−281−8.1%ReducedHolders
Q1 20223,484$909.0K0.1%−141−3.9%ReducedHolders
Q4 20213,625$796.0K<0.1%+2,185+151.7%AddedHolders
Q3 20211,440$261.0K<0.1%+6+0.4%AddedHolders
Q2 20211,434$289.0K<0.1%+33+2.4%AddedHolders
Q1 20211,401$301.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.